Independent report

Semi-synthetic cannabinoids related to tetrahydro-cannabinol and cannabidiol

ACMD review into the use and harms of SSCs and THCA to identify compounds causing harm which are not captured by the current generic definition for cannabinoids.

Documents

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The ACMD has conducted a review into the use and harms of semi-synthetic cannabinoids (SSCs) and tetrahydro-cannabinol acid (THCA), with the aims of identifying specific compounds causing health and social harms that are not captured by the current generic definition for cannabinoids.

The ACMD recommends that these compounds should be controlled under the Misuse of Drugs Act 1971 (MDA) under Class B and Schedule I of the Misuse of Drugs Regulations 2001 (MDR).

The ACMD also recommends that the UK generic text for cannabinoids in the MDA should be updated so that psychoactive semi-synthetic cannabinoids will be captured and controlled under legislation.

These publications are not fully accessible. We will provide accessible versions as soon as possible.

Read more about our聽accessible documents policy.

Updates to this page

Published 22 May 2025
Last updated 23 May 2025 show all updates
  1. Accessible (HTML) version of covering letter added.

  2. First published.

Sign up for emails or print this page